SPOTLIGHT: Thailand reconsiders compulsory licenses

Thailand's new public health minister has pledged to review his country's compulsory licensing of four cancer medicines--two made by Novartis, one by Sanofi-Aventis, and another by Roche. Under the previous minister, Thailand was aggressively using compulsory licenses to circumvent patent protection on drugs so it could obtain lower-cost versions. Report